GlobalData : Expanding reprocessing options for single-use cardiovascular devices are helping healthcare providers reduce costs, says GlobalData
June 13, 2022 at 05:03 am EDT
Share
13 Jun 2022
Expanding reprocessing options for single-use cardiovascular devices are helping healthcare providers reduce costs, says GlobalData
Posted in Medical Devices
With the reuse of costly devices offering significant cost savings to healthcare providers while reducing environmental impacts, reprocessing options for cardiovascular devices are expanding to include devices initially limited to single-use applications, observes GlobalData, a leading data and analytics company.
Jacob Fletcher, Medical Analyst at GlobalData, comments: "Single-use cardiovascular devices like diagnostic electrophysiology catheters, for example, have become increasingly sophisticated in design and function in recent years. As improved technologies are rapidly adopted, healthcare providers often face the challenge of balancing care with rising device costs. Device reprocessing offers a means of controlling procedure."
Due to the risk of contamination, device reprocessing is subject to strict regulation in most regions. In the US, the FDA selects which single-use devices are eligible for reprocessing based on the device's design and overall risk. Third-party device reprocessors, like NEScientific and Innovative Health, are subject to the same regulations as original equipment manufacturers, and must obtain FDA 510(k) clearances for devices they include in their portfolio. Collaboration between device manufacturers, reprocessors, and regulatory bodies is needed to further enable device reuse.
Professional reprocessing companies are continuously improving their capabilities to service more complex devices. A prime example of this came from device reprocessor Innovative Health, as the company announced it had received clearance to reprocess the market leading Philips Eagle Eye Platinum Intravascular Ultrasound (IVUS) catheter. According to GlobalData, IVUS catheter sales in the US amounted to over $315 million last year, with individual catheters averaging nearly $750 per unit. Opportunities to reduce repurchasing of these advanced devices could help to keep the technology accessible to patients.
Fletcher adds: "As device reprocessors work to expand their device catalogues, reuse of once single-use devices may become more of a common practice. High-cost environments like cardiac catherization and electrophysiology labs stand to benefit especially, improving their financial stability and ability to provide patient care."
Attachments
Original Link
Original Document
Permalink
Disclaimer
GlobalData plc published this content on 13 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 June 2022 09:02:11 UTC.
GlobalData Plc is a United Kingdom-based intelligence provider. The Company's principal activity is to provide business information in the form of proprietary data, analytics, and insights to clients in multiple sectors. The Company maintains a centralized operating model and single product platform (One Platform), which is underpinned by a common taxonomy, shared development resource, and new data science technologies. The Company offers Intelligence Centers, which includes market intelligence and thematic intelligence; Consultancy, which provides custom solutions, and Marketplace, which includes report store, company profiles, direct data services, newsletters and free intelligence. It serves corporates, financial institutions, professional services and others. It covers various industries, including aerospace, defense and security, agribusiness, apparel, automotive, banking and payments, construction, consumer, foodservice, healthcare, insurance, medical devices, and mining.